Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53

被引:0
|
作者
Lisa S St. John
Edward R Sauter
Meenhard Herlyn
Samuel Litwin
Karen Adler-Storthz
机构
[1] Dental Branch,Department of Basic Sciences
[2] Graduate School of Biomedical Sciences,Department of Biostatistics
[3] University of Texas-Houston Health Science Center,undefined
[4] The Wistar Institute,undefined
[5] Fox Chase Cancer Center,undefined
来源
Cancer Gene Therapy | 2000年 / 7卷
关键词
p53; squamous cell carcinoma; growth arrest; apoptosis; WAF1; WAF1; p21.;
D O I
暂无
中图分类号
学科分类号
摘要
Prior reports suggest that p53 protein status may influence the response to gene transduction with wild-type (wt) p53. Adenoviral vectors containing the p53 gene were administered to normal keratinocytes, to squamous cell carcinoma (SCC) lines with varied p53 protein status (absent, mutant, wt, or degraded by papillomavirus), as well as to tumors formed in severe combined immunodeficient mice. The percentage of cells undergoing apoptosis, G1 growth arrest, WAF1/p21 induction, and in vivo tumor progression were studied after wt p53 gene transduction. Apoptosis developed first in normal keratinocytes, next in SCCs lacking p53 protein, and last in SCCs with mutant or degraded p53 protein. All of the cell lines studied demonstrated an increase in WAF1/p21 protein, but only those lacking p53 protein showed G1 arrest. Tumors lacking p53 protein were more susceptible to p53 overexpression than those containing mutant or degraded p53 protein. The endogenous p53 protein status of SCCs appears to influence the outcome of p53 gene transduction.
引用
收藏
页码:749 / 756
页数:7
相关论文
共 50 条
  • [31] p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma
    Kusama, K
    Okutsu, S
    Takeda, A
    Himiya, T
    Kojima, A
    Kidokoro, Y
    Chu, L
    Iwanari, S
    Kudo, I
    Moro, I
    JOURNAL OF PATHOLOGY, 1996, 178 (04) : 415 - 421
  • [32] Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion
    Zhang, Jin
    Kong, Xiangmudong
    Yang, Hee Jung
    Mohibi, Shakur
    Lucchesi, Christopher August
    Zhang, Weici
    Chen, Xinbin
    CANCERS, 2024, 16 (01)
  • [33] The effect of wild-type p53 on the response of K562 to EMP
    Xie Xue-Jun
    Guo Yao
    Zeng Gui-Ying
    Guo Guo-Zheng
    CEEM' 2006: ASIA-PACIFIC CONFERENCE ON ENVIRONMENTAL ELECTROMAGNETICS, VOLS 1 AND 2, PROCEEDINGS, 2006, : 353 - 355
  • [34] Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity
    Moore, Lynette
    Lu, Xiongbin
    Ghebranious, Nader
    Tyner, Stuart
    Donehower, Lawrence A.
    MECHANISMS OF AGEING AND DEVELOPMENT, 2007, 128 (11-12) : 717 - 730
  • [35] Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation
    De Smet, Frederik
    Rubio, Mirian Saiz
    Hompes, Daphne
    Naus, Evelyne
    De Baets, Greet
    Langenberg, Tobias
    Hipp, Mark S.
    Houben, Bert
    Claes, Filip
    Charbonneau, Sarah
    Blanco, Javier Delgado
    Plaisance, Stephane
    Ramkissoon, Shakti
    Ramkissoon, Lori
    Simons, Colinda
    van den Brandt, Piet
    Weijenberg, Matty
    Van England, Manon
    Lambrechts, Sandrina
    Amant, Frederic
    D'Hoore, Andre
    Ligon, Keith L.
    Sagaert, Xavier
    Schymkowitz, Joost
    Rousseau, Frederic
    JOURNAL OF PATHOLOGY, 2017, 242 (01) : 24 - 38
  • [36] Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
    Alexandra Sullivan
    Nelofer Syed
    Milena Gasco
    Daniele Bergamaschi
    Giuseppe Trigiante
    Marlene Attard
    Louise Hiller
    Paul J Farrell
    Paul Smith
    Xin Lu
    Tim Crook
    Oncogene, 2004, 23 : 3328 - 3337
  • [37] Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
    Sullivan, A
    Syed, N
    Gasco, M
    Bergamaschi, D
    Trigiante, G
    Attard, M
    Hiller, L
    Farrell, PJ
    Smith, P
    Lu, X
    Crook, T
    ONCOGENE, 2004, 23 (19) : 3328 - 3337
  • [38] Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus-Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial Dysplasia
    Novack, Rachel
    Chapman, Erin
    Gao, Jiangyuan
    Horst, Basil
    Hoang, Lynn N.
    Ng, Tony L.
    Ko, Yen Chen Kevin
    MODERN PATHOLOGY, 2023, 36 (12)
  • [39] Implications of p53 alterations and anti-p53 antibody response in head and neck squamous cell carcinomas
    Lavieille, JP
    Righini, C
    Reyt, E
    Brambilla, C
    Riva, C
    ORAL ONCOLOGY, 1998, 34 (02): : 84 - 92
  • [40] Correlation between p53 gene mutation, p53 protein labeling and PCNA expression in oral squamous cell carcinomas
    van Heerden, WFP
    Van Rensburg, EJ
    Hemmer, J
    Raubenheimer, EJ
    Engelbrecht, S
    ANTICANCER RESEARCH, 1998, 18 (1A) : 237 - 240